Iron storage disease in Asia-Pacific populations: The importance of non-HFE mutations

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 7, 2013, Pages 1087-1094

  Mcdonald, Cameron J ^a   Wallace, Daniel F ^a   Crawford, Darrell H G ^b   Subramaniam, V Nathan ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Ferroportin disease; Hemochromatosis; Juvenile iron overload; Kupffer cell

Indexed keywords

FERROPORTIN; HEMOJUVELIN; HEPCIDIN; IRON; IRON CHELATING AGENT; TRANSFERRIN RECEPTOR 2;

ASIA; ASIAN; FERROPORTIN DISEASE; GENE FUNCTION; HEMOCHROMATOSIS; HEMOSIDEROSIS; HUMAN; INTERNALIZATION; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 84879437680     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12222     Document Type: Review

References (75)

1. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193-207.
2. Feder JN, Gnirke A, Thomas W etal. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 1996; 13: 399-408.
3. Wallace DF, Subramaniam VN. Non-HFE haemochromatosis. World J. Gastroenterol. 2007; 13: 4690-4698.
4. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 1997; 34: 275-278.
5. Murphy S, Curran MD, McDougall N, Callender ME, O'Brien CJ, Middleton D. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population-implications for haemochromatosis. Tissue Antigens 1998; 52: 484-488.
6. Nemeth E, Tuttle MS, Powelson J etal. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093.
7. Pigeon C, Ilyin G, Courselaud B etal. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 2001; 276: 7811-7819.
8. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-4433.
9. Chang JG, Liu TC, Lin SF. Rapid diagnosis of the HLA-H gene Cys 282 Tyr mutation in hemochromatosis by polymerase chain reaction-a very rare mutation in the Chinese population. Blood 1997; 89: 3492-3493.
10. Sohda T, Yanai J, Soejima H, Tamura K. Frequencies in the Japanese population of HFE gene mutations. Biochem. Genet. 1999; 37: 63-68.
11. Kaur G, Rapthap CC, Xavier M etal. Distribution of C282Y and H63D mutations in the HFE gene in healthy Asian Indians and patients with thalassaemia major. Natl Med. J. India 2003; 16: 309-310.
12. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002; 122: 646-651.
13. Walsh A, Dixon JL, Ramm GA etal. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin. Gastroenterol. Hepatol. 2006; 4: 1403-1410.
14. Sohda T, Okubo R, Kamimura S, Ohkawara T. Hemochromatosis with HFE gene mutation in a Japanese patient. Am. J. Gastroenterol. 2001; 96: 2487-2488.
15. Yonal O, Hatirnaz O, Akyuz F etal. Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey. Turk. J. Gastroenterol. 2007; 18: 53-57.
16. Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJ. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet. Test. 2000; 4: 151-161.
17. Silva B, Martins R, Proenca D, Fleming R, Faustino P. The functional significance of E277K and V295A HFE mutations. Br. J. Haematol. 2012; 158: 399-408.
18. Bradbury R, Fagan E, Payne SJ. Two novel polymorphisms (E277K and V212V) in the haemochromatosis gene HFE. Hum. Mutat. 2000; 15: 120.
19. Karimi M, Yavarian M, Delbini P etal. Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in beta-thalassemia major and the first E277K homozygous. Hematol. J. 2004; 5: 524-527.
20. Mendes AI, Ferro A, Martins R etal. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes. Ann. Hematol. 2008; 88: 229-234.
21. Takano A, Niimi H, Atarashi Y etal. A novel Y231del mutation of HFE in hereditary haemochromatosis provides in vivo evidence that the Huh-7 is a human haemochromatotic cell line. Liver Int. 2011; 31: 1593-1597.
22. Vecchi C, Montosi G, Pietrangelo A. Huh-7: a human "hemochromatotic" cell line. Hepatology 2010; 51: 654-659.
23. Steiner M, Ocran K, Genschel J etal. A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology 2002; 122: 789-795.
24. Pointon JJ, Viprakasit V, Miles KL etal. Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload. Blood Cells Mol. Dis. 2003; 30: 302-306.
25. Viprakasit V, Vathesathokit P, Chinchang W etal. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder. Eur. J. Haematol. 2004; 73: 43-49.
26. Steiner M, Leiendecker-Foster C, McLaren GD etal. Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A in North American Vietnamese with and without phenotypic evidence of iron overload. Transl. Res. 2007; 149: 92-95.
27. De Gobbi M, Roetto A, Piperno A etal. Natural history of juvenile haemochromatosis. Br. J. Haematol. 2002; 117: 973-979.
28. Roetto A, Totaro A, Cazzola M etal. Juvenile hemochromatosis locus maps to chromosome 1q. Am. J. Hum. Genet. 1999; 64: 1388-1393.
29. Papanikolaou G, Samuels ME, Ludwig EH etal. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 2004; 36: 77-82.
30. Babitt JL, Huang FW, Wrighting DM etal. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 2006; 38: 531-539.
31. Truksa J, Gelbart T, Peng H, Beutler E, Beutler B, Lee P. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Br. J. Haematol. 2009; 147: 571-581.
32. Le Gac G, Scotet V, Ka C etal. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum. Mol. Genet. 2004; 13: 1913-1918.
33. Wallace DF, Dixon JL, Ramm GA, Anderson GJ, Powell LW, Subramaniam N. Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families. Haematologica 2005; 90: 254-255.
34. Lok CY, Merryweather-Clarke AT, Viprakasit V etal. Iron overload in the Asian community. Blood 2009; 114: 20-25.
35. Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD. Identification of a novel mutation (C321X) in HJV. Blood 2004; 104: 2176-2177.
36. Koyama C, Hayashi H, Wakusawa S etal. Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J. Hepatol. 2005; 43: 740-742.
37. Nagayoshi Y, Nakayama M, Suzuki S etal. A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis. Eur. J. Heart Fail. 2008; 10: 1001-1006.
38. Roetto A, Papanikolaou G, Politou M etal. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 2003; 33: 21-22.
39. Delatycki MB, Allen KJ, Gow P etal. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis. Clin. Genet. 2004; 65: 378-383.
40. Hattori A, Tomosugi N, Tatsumi Y etal. Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis. Blood Cells Mol. Dis. 2012; 48: 179-182.
41. Camaschella C, Roetto A, Cali A etal. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 2000; 25: 14-15.
42. Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 2000; 275: 16618-16625.
43. Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 2006; 281: 28494-28498.
44. Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009; 9: 217-227.
45. D'Alessio F, Hentze MW, Muckenthaler MU. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. J. Hepatol. 2012; 57: 1052-1060.
46. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009; 50: 1992-2000.
47. Schmidt PJ, Fleming MD. Transgenic HF. E-dependent induction of hepcidin in mice does not require transferrin receptor-2. Am. J. Hematol. 2012; 87: 588-595.
48. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 2005; 105: 1803-1806.
49. Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C, Frebourg T. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. Br. J. Haematol. 2004; 125: 674-678.
50. Hattori A, Wakusawa S, Hayashi H etal. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol. Res. 2003; 26: 154-156.
51. Zamani F, Bagheri Z, Bayat M etal. Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations. Med. Sci. Monit. 2012; 18: CR622-629.
52. Koyama C, Wakusawa S, Hayashi H etal. Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. Haematologica 2005; 90: 302-307.
53. Hsiao PJ, Tsai KB, Shin SJ etal. A novel mutation of transferrin receptor 2 in a Taiwanese woman with type 3 hemochromatosis. J. Hepatol. 2007; 47: 303-306.
54. Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol. Dis. 2001; 27: 285-289.
55. Hayashi H, Wakusawa S, Motonishi S etal. Genetic background of primary iron overload syndromes in Japan. Intern. Med. 2006; 45: 1107-1111.
56. Wallace DF, Harris JM, Subramaniam VN. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype. Am. J. Physiol. Cell Physiol. 2010; 298: C75-84.
57. Liu XB, Yang F, Haile DJ. Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Dis. 2005; 35: 33-46.
58. Schimanski LM, Drakesmith H, Merryweather-Clarke AT etal. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 2005; 105: 4096-4102.
59. Pietrangelo A, Montosi G, Totaro A etal. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 725-732.
60. Drakesmith H, Schimanski LM, Ormerod E etal. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 2005; 106: 1092-1097.
61. Eason RJ, Adams PC, Aston CE, Searle J. Familial iron overload with possible autosomal dominant inheritance. Aust. N. Z. J. Med. 1990; 20: 226-230.
62. Arden KE, Wallace DF, Dixon JL etal. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut 2003; 52: 1215-1217.
63. Subramaniam VN, Wallace DF, Dixon JL, Fletcher LM, Crawford DH. Ferroportin disease due to the A77D mutation in Australia. Gut 2005; 54: 1048-1049.
64. Wallace DF, Pedersen P, Dixon JL etal. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 2002; 100: 692-694.
65. Wallace DF, Clark RM, Harley HA, Subramaniam VN. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J. Hepatol. 2004; 40: 710-713.
66. Wallace DF, Dixon JL, Ramm GA, Anderson GJ, Powell LW, Subramaniam VN. A novel mutation in ferroportin implicated in iron overload. J. Hepatol. 2007; 46: 921-926.
67. Wallace DF, Browett P, Wong P, Kua H, Ameratunga R, Subramaniam VN. Identification of ferroportin disease in the Indian subcontinent. Gut 2005; 54: 567-568.
68. Agarwal S, Sankar VH, Tewari D, Pradhan M. Ferroportin (SLC40A1) gene in thalassemic patients of Indian descent. Clin. Genet. 2006; 70: 86-87.
69. McDonald CJ, Wallace DF, Ostini L, Bell SJ, Demediuk B, Subramaniam VN. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective. J. Hepatol. 2011; 54: 538-544.
70. Cremonesi L, Forni GL, Soriani N etal. Genetic and clinical heterogeneity of ferroportin disease. Br. J. Haematol. 2005; 131: 663-670.
71. Jouanolle AM, Douabin-Gicquel V, Halimi C etal. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J. Hepatol. 2003; 39: 286-289.
72. Koyama C, Wakusawa S, Hayashi H etal. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron. Intern. Med. 2005; 44: 990-993.
73. Fernandes A, Preza GC, Phung Y etal. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009; 114: 437-443.
74. Liu W, Shimomura S, Imanishi H etal. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene. Intern. Med. 2005; 44: 285-289.
75. Kato J, Fujikawa K, Kanda M etal. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am. J. Hum. Genet. 2001; 69: 191-197.